VCU Massey Cancer Center

Menu

2013 Archive

Ross B. Mikkelsen, Ph.D.

Shaping the minds of future cancer researchers

Cancer researcher Ross B. Mikkelsen, Ph.D., member of the Radiation Biology and Oncology research program at VCU Massey Cancer Center tells his students, “researchers aren’t stupid because we make stupid mistakes, but because we don’t know what’s on the other side of an experiment. On the other hand, when you do find out what’s on the other side, you get a high that you can’t beat.”

Continue reading →

Top 5 blog posts

Top 5 stories from 2013

2013 brought on some great new research from Massey. Here are the top five stories from the past year: 1. Targeted viral therapy destroys breast cancer stem cells in preclinical experiments 2. Drug combination therapy causes cancer cells to "eat themselves" 3. From head to toe: how to perform a skin self-exam 4. Researchers look to mathematics, nature...

Continue reading →

Our Health Richmond Bedside Manner

Six Massey physicians earn 2013 Best Bedside Manner recognition

In the December 2013 issue of Our Health Richmond magazine, six Massey physicians were recognized for their kindness, empathy and attentiveness when working with patients. These inaugural Best Bedside Manner Awards seek to recognize professionals who incorporate compassionate care into their practice.

Continue reading →

Keggleman Fisher Das

Scientists uncover new target for brain cancer treatment

A new study is giving researchers hope that novel targeted therapies can be developed for glioblastoma multiforme (GBM), the most common and most aggressive form of brain cancer, after demonstrating for the first time that a gene known as melanoma differentiation associated gene-9/syntenin (mda-9/syntenin) is a driving force behind the disease’s aggressive and invasive nature.

Continue reading →

Paul Fisher at his desk.

Researchers hope newly discovered gene interaction could lead to novel cancer therapies

Scientists from Virginia Commonwealth University have revealed how two genes interact to kill a wide range of cancer cells. Originally discovered by the study’s lead investigator Paul B. Fisher, M.Ph., Ph.D., the genes known as mda-7/IL-24 and SARI could potentially be harnessed to treat both primary and metastatic forms of brain, breast, colon, lung, ovary, prostate, skin and other cancers.

Continue reading →